Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.
about
Prothymosin alpha interacts with the CREB-binding protein and potentiates transcription.Ligand-independent activation of oestrogen receptor alpha by caveolin-1The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growthA conserved lysine in the estrogen receptor DNA binding domain regulates ligand activation profiles at AP-1 sites, possibly by controlling interactions with a modulating repressorLigand-induced estrogen receptor alpha degradation by the proteasome: new actors?HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory DiseasesBRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?Regulation of Estrogen Receptor α by the SET7 Lysine MethyltransferaseStructural Basis for Ca2+-induced Activation and Dimerization of Estrogen Receptor by CalmodulinMICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functionsP21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epitheliumMetastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cellsThe cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signalingCyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanismAn acetylation switch modulates the transcriptional activity of estrogen-related receptor alphaThe prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancerPost-translational modification of nuclear co-repressor receptor-interacting protein 140 by acetylationAcquisition of sexual receptivity: roles of chromatin acetylation, estrogen receptor-alpha, and ovarian hormones.Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sitesBRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.Protein modifications as potential biomarkers in breast cancer.Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.Minireview: The versatile roles of lysine deacetylases in steroid receptor signalingLiver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1.The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer.Oestrogens and spermatogenesis.Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein.Palmitoylation: a protein S-acylation with implications for breast cancer.Research resource: comparison of gene profiles from wild-type ERα and ERα hinge region mutants.Estrogen receptor mutations and changes in downstream gene expression and signalingAndrogen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via p300-mediated recruitment to active foci, acetylation, and increased DNA binding.Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs.The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.Acetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cellsSIRT1 is regulated by a PPAR{γ}-SIRT1 negative feedback loop associated with senescence.Estrogen receptors: orchestrators of pleiotropic cellular responses.Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors.Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies?
P2860
Q24522580-4FB7479A-C799-40B4-A43A-BE0682FE7647Q24533468-445336BE-0142-4E3F-9B24-48046F9AE9AAQ24658169-3C8FA8A0-C84B-4530-A42D-5E25DE2A0B4CQ24801123-49A48D6C-6E1A-4E5F-B845-C84C73FA17ECQ25257822-7B91AFFD-11E0-4124-BF8D-2D791B33CFEDQ26739120-81DAAEB5-D924-4DE2-AE78-E85CF603F7F1Q26822737-29091948-D73A-4791-B84A-04ECA18812B9Q27650581-449E0A01-B4C3-4F91-9B3A-9A8811766A6DQ27676878-8D6F7B08-4ED6-49F7-AE89-7A38167FE654Q28183743-B7D8A79B-9C92-4A36-BA7D-DDDF0D56312AQ28206589-228371DC-0B62-4398-9E6A-314C817C78CAQ28237005-F75D6D43-88DA-4634-9B4A-CE946771AE61Q28252084-50F2E5BD-CB30-44D9-9600-3A736141C584Q28256059-C29EB2D7-6A44-4340-A29C-149EAD2F08B6Q28282893-AE482016-69B0-43D6-8563-538979284E04Q28485944-3F05F253-A96F-4CAB-BEBE-F98E1D0AC2D3Q28589752-876613D6-3F87-4FAE-B23E-5D0AA8F36992Q30425720-A0052FD9-10B7-489A-A450-7F69DF55E815Q33382611-9154D7C3-B8EC-4B38-9B8C-28FE2B91031DQ33576505-D28118D4-91AA-43C2-AAEE-89A3921C2859Q33586407-1DC8FACB-BC11-4C10-AE73-8BA6AA65846EQ33598764-49A41A10-1789-4C66-8BE2-F0DF0CC6024EQ33632070-C0BA3ED1-20E8-43AE-9981-13DD392852D5Q33642453-86D4443C-01D4-4DC9-A363-554EE5D284D1Q33699615-5E893150-ED65-426A-810C-8E7484CB8A95Q33704579-4E6AA5B7-5C19-4FEA-8761-40BFD02E9B45Q33856966-B5ADC37C-EC28-4206-8842-006296D90729Q33889528-B8847318-DA7A-40A4-93D6-46C8C463F0B0Q33915087-25EF7E99-C2DF-430E-B7A6-47314E498A5BQ33977429-DA02FE2D-F0CC-4A40-B6EA-8DBF3221C6B1Q34112728-B06F1025-CF31-4525-A897-1E347B99ACD8Q34125103-41311FBB-845B-440C-9F81-823D10BD879DQ34150815-ECE05D98-DCA6-4AC3-9DA4-58EB33222BA9Q34171631-FB2653F8-5644-42EA-A5F5-E1C81691509FQ34318315-E24F775B-0E64-40A0-A29E-7669F7FA3097Q34365660-5DEFA790-6485-4A82-89B0-FDE12AE914A2Q34367932-A235F13F-F81B-480B-985B-1AFE416C75B6Q34371045-1B6A270A-5A7A-4AF7-B710-BBC553D4C193Q34416994-2264266C-1D22-4708-87E3-FC02995445FEQ34417159-69EC88AC-715B-4D98-BA8D-F0FFD6B6A900
P2860
Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Direct acetylation of the estr ...... ation and hormone sensitivity.
@ast
Direct acetylation of the estr ...... ation and hormone sensitivity.
@en
type
label
Direct acetylation of the estr ...... ation and hormone sensitivity.
@ast
Direct acetylation of the estr ...... ation and hormone sensitivity.
@en
prefLabel
Direct acetylation of the estr ...... ation and hormone sensitivity.
@ast
Direct acetylation of the estr ...... ation and hormone sensitivity.
@en
P2093
P2860
P356
P1476
Direct acetylation of the estr ...... ation and hormone sensitivity.
@en
P2093
Albanese C
Angeletti RH
Katzenellenbogen BS
Kushner PJ
Lisanti MP
P2860
P304
18375-18383
P356
10.1074/JBC.M100800200
P407
P577
2001-03-09T00:00:00Z